cAMP mediates homologous downregulation of PAF receptor mRNA expression in mesangial cells

Area of Science:

• Molecular Biology
• Cell Signaling
• Renal Physiology

Background:

• Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and immune responses.
• Understanding the regulation of PAF receptor expression is crucial for elucidating PAF signaling pathways.
• Homologous desensitization, where a ligand reduces its own receptor expression, is a key regulatory mechanism.

Purpose of the Study:

• To investigate the molecular mechanism of homologous desensitization of platelet-activating factor (PAF) signaling.
• To examine the effect of PAF on PAF receptor mRNA expression in cultured rat mesangial cells.
• To identify the signaling molecules involved in PAF-induced downregulation of its receptor.

Main Methods:

• Northern blot analysis was used to quantify PAF receptor mRNA expression.
• Rat mesangial cells were treated with PAF, a PAF receptor antagonist (WEB-2086), or a cyclooxygenase inhibitor (indomethacin).
• Radioimmunoassays were employed to measure prostaglandin E2 (PGE2) and cyclic adenosine monophosphate (cAMP) formation.

Main Results:

• PAF treatment (10(-7)-10(-8) M) significantly reduced PAF receptor mRNA expression within 1 hour.
• This reduction was reversed by pretreatment with a PAF receptor antagonist or a cyclooxygenase inhibitor.
• PGE2 and cAMP formation were stimulated by PAF, and their levels mimicked the reduction in PAF receptor mRNA when applied exogenously.

Conclusions:

• PAF induces homologous downregulation of its own receptor mRNA expression in cultured mesangial cells.
• This downregulation is mediated by a signaling cascade involving prostaglandin E2 (PGE2) synthesis.
• Increased cyclic adenosine monophosphate (cAMP) production, downstream of PGE2, plays a critical role in the desensitization process.